Lataa...
Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
BACKGROUND: The number of people with type 2 diabetes mellitus (T2DM) is increasing worldwide. The combination of metformin and sulphonylurea (M+S) is a widely used treatment. Whether M+S shows better or worse effects in comparison with other antidiabetic medications for people with T2DM is still co...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2019
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6472662/ https://ncbi.nlm.nih.gov/pubmed/30998259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012368.pub2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|